Acne Treatment Market Analysis Overview:

In a recent research report by Market Research Community, the acne treatment market is expected to surpass USD 13.00 Billion by the year 2030, from USD 8.67 Billion in 2021.

The skin has microscopic openings called pores, which can become clogged by dirt, oil, germs, and dead skin cells which leads to a pimple, also known as a zit or blemish. To treat this acne various treatments are used via oral or tropics route.

Top Key Players of the Acne Treatment Market:
GlaxoSmithKline plc., Almirall S.A., Galderma Laboratories, Hoffman La Roche Ltd, Bausch Health Companies Inc, Leo Pharma A/S, Johnson & Johnson Services Inc, Teva Pharmaceutical Industries Ltd, Candela Corporation, Vyne Therapeutics Inc.

The retinoids category is anticipated to grow at a faster CAGR by 2030, due to the increased prevalence of moderate to severe acne and the consequent increase in retinoid demand. For instance, Sun Pharmaceutical Industries Ltd. announced in February 2020 that ABSORICA LD (Isotretinoin) capsules would be available in the United States to treat individuals 12 years of age and older with severe recalcitrant nodular acne.

Regional Analysis:
North America– (U.S., Canada, Mexico)
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe)
Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific)
Latin America- (Brazil, Argentina, Chile, Rest of Latin America)
Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA)

Further, due to the region's expanding patient base, big corporations' significant R&D expenditures on medications used to treat dermatological disorders, and a rise in the use of cutting-edge treatment goods, Europe will represent the second-largest shareholder. Due to expanding public awareness of various pharmaceuticals and an increase in businesses entering the Asian market, Asia Pacific is predicted to have the greatest CAGR during the forecast period.

The acne treatment market is projected to grow at a significant pace reaching a CAGR of approximately 4.6%, over the forecast period of 2022–2030, despite a considerable fall in product sales during the initial phase of pandemic spread and lockdown restrictions imposed globally.

The study is consolidated into major segments and further into sub-segments, such as by Product (Retinoids, Antibiotics, Isotretinoin, Others), by Route of Administration (Oral, Tropics) by Age Group (10-17, 18-14, 46-64, 65 Above) to forecast the market size by value; also includes the analysis of past market dynamics from 2016 – 2021, considering 2021 as the base year.

Get Full Report @ 

The research provides answers to the following key questions:                                                                                                                                                                                                                                                                                                                                                                                               

  • What type of customers buying the products and services from companies operating in the Acne Treatment Market?
  • What will be the roadmap for the product manufacturers operating in the Acne Treatmentindustry for the forecast period, 2022 to 2030?
  • What are the recent developments in the competitive landscape to look out for during the estimated period?
  • What are the major trends influencing customers’ lives and their buying behaviour?
  • How can brands best communicate with the customers they intend to target?
  • When, where and how the customers want to use or consume the products or services?